New drug cocktail aims to control follicular lymphoma without chemo
NCT ID NCT07585747
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study tests a combination of three drugs (orelabrutinib, tafasitamab, and lenalidomide) as a first treatment for people with follicular lymphoma, a slow-growing blood cancer. The goal is to see how well the drugs shrink or eliminate tumors and to check for side effects. About 27 newly diagnosed adults who need treatment will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Institute of Hematology & Blood Diseases Hospital, China
Tianjin, Tianjin Municipality, 300020, China
-
Qilu Hospital of Shandong Province
Jinan, Shandong, China
Contact Phone: •••-•••-••••
-
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
Contact Phone: •••-•••-••••
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.